S&P 500   4,396.28 (+1.07%)
DOW   34,620.50 (+1.32%)
QQQ   349.44 (+1.41%)
AAPL   163.18 (+2.19%)
MSFT   306.40 (+3.27%)
FB   300.90 (+2.13%)
GOOGL   2,643.97 (+2.29%)
AMZN   2,864.82 (+3.15%)
TSLA   875.89 (-6.56%)
NVDA   226.29 (-0.63%)
BABA   114.04 (+0.59%)
NIO   22.03 (-2.78%)
AMD   106.61 (-3.70%)
CGC   7.04 (-2.63%)
MU   81.59 (-0.46%)
GE   90.45 (+1.27%)
T   24.32 (+0.29%)
F   19.99 (+0.40%)
DIS   137.70 (+3.07%)
AMC   15.13 (-5.08%)
PFE   54.53 (+2.87%)
ACB   3.93 (-3.20%)
BA   194.82 (+0.28%)
S&P 500   4,396.28 (+1.07%)
DOW   34,620.50 (+1.32%)
QQQ   349.44 (+1.41%)
AAPL   163.18 (+2.19%)
MSFT   306.40 (+3.27%)
FB   300.90 (+2.13%)
GOOGL   2,643.97 (+2.29%)
AMZN   2,864.82 (+3.15%)
TSLA   875.89 (-6.56%)
NVDA   226.29 (-0.63%)
BABA   114.04 (+0.59%)
NIO   22.03 (-2.78%)
AMD   106.61 (-3.70%)
CGC   7.04 (-2.63%)
MU   81.59 (-0.46%)
GE   90.45 (+1.27%)
T   24.32 (+0.29%)
F   19.99 (+0.40%)
DIS   137.70 (+3.07%)
AMC   15.13 (-5.08%)
PFE   54.53 (+2.87%)
ACB   3.93 (-3.20%)
BA   194.82 (+0.28%)
S&P 500   4,396.28 (+1.07%)
DOW   34,620.50 (+1.32%)
QQQ   349.44 (+1.41%)
AAPL   163.18 (+2.19%)
MSFT   306.40 (+3.27%)
FB   300.90 (+2.13%)
GOOGL   2,643.97 (+2.29%)
AMZN   2,864.82 (+3.15%)
TSLA   875.89 (-6.56%)
NVDA   226.29 (-0.63%)
BABA   114.04 (+0.59%)
NIO   22.03 (-2.78%)
AMD   106.61 (-3.70%)
CGC   7.04 (-2.63%)
MU   81.59 (-0.46%)
GE   90.45 (+1.27%)
T   24.32 (+0.29%)
F   19.99 (+0.40%)
DIS   137.70 (+3.07%)
AMC   15.13 (-5.08%)
PFE   54.53 (+2.87%)
ACB   3.93 (-3.20%)
BA   194.82 (+0.28%)
S&P 500   4,396.28 (+1.07%)
DOW   34,620.50 (+1.32%)
QQQ   349.44 (+1.41%)
AAPL   163.18 (+2.19%)
MSFT   306.40 (+3.27%)
FB   300.90 (+2.13%)
GOOGL   2,643.97 (+2.29%)
AMZN   2,864.82 (+3.15%)
TSLA   875.89 (-6.56%)
NVDA   226.29 (-0.63%)
BABA   114.04 (+0.59%)
NIO   22.03 (-2.78%)
AMD   106.61 (-3.70%)
CGC   7.04 (-2.63%)
MU   81.59 (-0.46%)
GE   90.45 (+1.27%)
T   24.32 (+0.29%)
F   19.99 (+0.40%)
DIS   137.70 (+3.07%)
AMC   15.13 (-5.08%)
PFE   54.53 (+2.87%)
ACB   3.93 (-3.20%)
BA   194.82 (+0.28%)
OTCMKTS:CLZNF

Clariant Stock Forecast, Price & News

$21.32
0.00 (0.00%)
(As of 01/25/2022 12:00 AM ET)
Add
Compare
Today's Range
$21.32
▼
$21.32
50-Day Range
$19.49
▼
$21.32
52-Week Range
$19.49
▼
$21.32
Volume
N/A
Average Volume
3,143 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
View Price History Chart DataSkip Price History Chart
30 days | 90 days | 365 days | Advanced Chart
Receive CLZNF News and Ratings via Email

Sign-up to receive the latest news and ratings for Clariant and its competitors with MarketBeat's FREE daily newsletter.


Clariant logo

About Clariant

Clariant AG engages in the development, manufacture, distribution, and sale of specialty chemicals. It operates through the following segments: Care Chemicals; Catalysis; Natural Resources; Plastics and Coatings; and Corporate. The Care Chemicals segment comprises the industrial and consumer specialties business unit (BU), food additives as well as the industrial biotechnology business. The Catalysis segment develops, manufactures, and sells a catalyst product for the chemical, fuel, and automotive industries. The Natural Resources segment comprises BUs oil and mining services and functional minerals. The Plastics and Coatings segment includes the BUs additives, pigments, and masterbatches. The company was founded in 1995 and is headquartered in Muttenz, Switzerland.

Headlines

Clariant AG Registered Shares (CLZNF)
January 16, 2022 |  nasdaq.com
Clariant to purchase BASF’s U.S. Attapulgite business assets
December 31, 2021 |  finance.yahoo.com
Clariant AG's (CLZNF) Management on Q3 2019 Results - Earnings Call Transcript
November 2, 2019 |  seekingalpha.com
See More Headlines

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Chemicals: Specialty
Sub-Industry
N/A
Sector
Process Industries
Current Symbol
OTCMKTS:CLZNF
Previous Symbol
CUSIP
N/A
CIK
1366235
Web
www.clariant.com
Phone
(161) 469-5111
Fax
N/A
Employees
11,342
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Price-To-Earnings

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable

MarketRank™

Overall MarketRank™

1.19 out of 5 stars

Analyst Opinion: 1.0Community Rank: 4.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Clariant (OTCMKTS:CLZNF) Frequently Asked Questions

Is Clariant a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Clariant in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Clariant stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLZNF, but not buy additional shares or sell existing shares.
View analyst ratings for Clariant or view top-rated stocks.

How has Clariant's stock been impacted by Coronavirus?

Clariant's stock was trading at $21.75 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CLZNF stock has decreased by 2.0% and is now trading at $21.32.
View which stocks have been most impacted by COVID-19.

Are investors shorting Clariant?

Clariant saw a decline in short interest in the month of December. As of December 15th, there was short interest totaling 132,100 shares, a decline of 77.1% from the November 30th total of 577,700 shares. Based on an average daily volume of 100 shares, the short-interest ratio is currently 1,321.0 days.
View Clariant's Short Interest.

What price target have analysts set for CLZNF?

2 Wall Street analysts have issued 1 year price objectives for Clariant's shares. Their forecasts range from $18.80 to $20.00. On average, they expect Clariant's share price to reach $19.40 in the next year. This suggests that the stock has a possible downside of 9.0%.
View analysts' price targets for Clariant or view top-rated stocks among Wall Street analysts.

Who are Clariant's key executives?

Clariant's management team includes the following people:
  • Conrad Keijzer, Chief Executive Officer
  • Hans Bohnen, Chief Operating Officer & Executive Vice President
  • Stephan Lynen, Chief Financial Officer & Executive Vice President
  • Maria Ivek, Senior Investor Relations Officer

Who are some of Clariant's key competitors?

Some companies that are related to Clariant include ALPEK (ALPKF), Denka (DENKF), EcoSynthetix (ECSNF), Global Helium (HECOF), LG Chem (LGCLF), Polymetals Resources (POL), Synthomer (SYYYF) and Tokuyama (TKYMF).
View all of CLZNF's competitors.

What is Clariant's stock symbol?

Clariant trades on the OTCMKTS under the ticker symbol "CLZNF."

How do I buy shares of Clariant?

Shares of CLZNF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Clariant's stock price today?

One share of CLZNF stock can currently be purchased for approximately $21.32.

How many employees does Clariant have?

Clariant employs 11,342 workers across the globe.

What is Clariant's official website?

The official website for Clariant is www.clariant.com.

Where are Clariant's headquarters?

Clariant is headquartered at Rothausstrasse 61, Muttenz, Basel-Landschaft (Basle.

How can I contact Clariant?

Clariant's mailing address is Rothausstrasse 61, Muttenz, Basel-Landschaft (Basle. The company can be reached via phone at (161) 469-5111.


This page was last updated on 1/27/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.